PRMT5 regulates epigenetic changes in suppressive Th1-like iTregs in response to IL-12 treatment
Authors:
Open Access
- 8 January 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1292049
Abstract
Background: Induced regulatory T cells (iTregs) are a heterogeneous population of immunosuppressive T cells with therapeutic potential. Treg cells show a range of plasticity and can acquire T effector-like capacities, as is the case for T helper 1 (Th1)-like iTregs. Thus, it is important to distinguish between functional plasticity and lineage instability. Aplastic anemia (AA) is an autoimmune disorder characterized by immune-mediated destruction of hematopoietic stem and progenitor cells in the bone marrow (BM). Th1-like 1 iTregs can be potent suppressors of aberrant Th1-mediated immune responses such as those that drive AA disease progression. Here we investigated the function of the epigenetic enzyme, protein arginine methyltransferase 5 (PRMT5), its regulation of the iTreg-destabilizing deacetylase, sirtuin 1 (Sirt1) in suppressive Th1-like iTregs, and the potential for administering Th1-like iTregs as a cell-based therapy for AA.Methods: We generated Th1-like iTregs by culturing iTregs with IL-12, then assessed their suppressive capacity, expression of iTreg suppression markers, and enzymatic activity of PRMT5 using histone symmetric arginine di-methylation (H3R2me2s) as a read out. We used ChIP sequencing on Th1 cells, iTregs, and Th1-like iTregs to identify H3R2me2s-bound genes unique to Th1-like iTregs, then validated targets using CHiP-qPCR. We knocked down PRMT5 to validate its contribution to Th1-like iTreg lineage commitment. Finally we tested the therapeutic potential of Th1-like iTregs using a Th1-mediated mouse model of AA.Results: Exposing iTregs to the Th1 cytokine, interleukin-12 (IL-12), during early events of differentiation conveyed increased suppressive function. We observed increased PRMT5 enzymatic activity, as measured by H3R2me2s, in Th1-like iTregs, which was downregulated in iTregs. Using ChIP-sequencing we discovered that H3R2me2s is abundantly bound to the Sirt1 promoter region in Th1-like iTregs to negatively regulate its expression. Furthermore, administering Th1-like iTregs to AA mice provided a survival benefit.Conclusions: Knocking down PRMT5 in Th1-like iTregs concomitantly reduced their suppressive capacity, supporting the notion that PRMT5 is important for the superior suppressive capacity and stability of Th1-like iTregs. Conclusively, therapeutic administration of Th1-like iTregs in a mouse model of AA significantly extended their survival and they may have therapeutic potential.Keywords
Funding Information
- U.S. Department of War
This publication has 49 references indexed in Scilit:
- Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2RPLOS ONE, 2012
- Versatility of PRMT5-induced methylation in growth control and developmentTrends in Biochemical Sciences, 2011
- Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophilsNature Immunology, 2011
- Sirtuin-1 Targeting Promotes Foxp3 + T-Regulatory Cell Function and Prolongs Allograft SurvivalMolecular and Cellular Biology, 2011
- Th17 immune responses contribute to the pathophysiology of aplastic anemiaBlood, 2010
- The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failureBlood, 2010
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fateNature, 2010
- Heterogeneity and plasticity of T helper cellsCell Research, 2009
- The functional plasticity of T cell subsetsNature Reviews Immunology, 2009
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009